PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.\', \'Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Clinical & Diagnostic Sciences, The University of Alabama at Birmingham, Birmingham, AL, USA.\', \'Cardiovascular Research Institute, School of Medicine, University of California San Francisco, San Francisco, California, USA.\', \'Department of Immunology and Transplantation, School of Medicine, Stanford University, Stanford, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7150/ijms.61779
?:doi
?:hasPublicationType
?:journal
  • International journal of medical sciences
is ?:pmid of
?:pmid
?:pmid
  • 34790054
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.9
?:rankingScore_hIndex
  • 45
is ?:relation_isRelatedTo_publication of
?:title
  • Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34790054>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34790054>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all